(Q44093244)

29 November 2017

title

A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). (English)

1 reference

29 November 2017

1 reference

R Michael Hofmann

1

1 reference

29 November 2017

Christine Maloney

series ordinal

2

1 reference

29 November 2017

David M Ward

series ordinal

3

1 reference

29 November 2017

Bryan N Becker

series ordinal

4

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

24

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

325-335

1 reference

Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Regional citrate anticoagulation in continuous venovenous hemodiafiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Hemorrhage during High-Risk Hemodialysis Using Controlled Heparinization

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Eye care for the critically ill

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Continuous arteriovenous hemofiltration. A report of six months' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120005366

21 January 2018

Identifiers

DOI

10.1081/JDI-120005366

1 reference

29 November 2017

1 reference